A simpler protein structure makes them more stable than their rodent counterparts, which translates into greater longevity and robustness over the course of experiments. Rabbit B-cells undergo a ...

The US Food and Drug Administration (FDA) has placed a clinical hold on the Phase I trial of Neumora Therapeutics’ schizophrenia therapy, NMRA-266. The decision for the clinical hold was based ...